News
Trump's DOJ reschedules medicinal marijuana, increasing acce...
The US Justice Department has issued an order moving medical marijuana to Schedule III, removing some barriers to access for patients and researchers.
Market Access
Fighting fake GLP-1s to protect patients & preserve trust
Counterfeit drug promotion is a patient safety, brand equity, and public trust issue.
News
AbbVie makes record investment in North Carolina plant
AbbVie's $100bn programme of facility investments in the US has continued with a new 185-acre campus in Durham, North Carolina.
News
FDA delays decision on Sanofi's subcutaneous Sarclisa
The FDA has extended its review of a new version of Sanofi's multiple myeloma Sarclisa that could help narrow the gap with arch-rival Darzalex.
News
Medicare obesity drug pilot extended after insurer pushback
Medicare will cover the cost of a pilot of weight-loss drug coverage, after health insurers refuse to take part.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
